Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
1st Sep 2016 7:00 am RNS AstraZeneca Completes Aspen Agreement
24th Aug 2016 7:00 am RNS AZ TO SELL ANTIBIOTICS BUSINESS TO PFIZER
18th Aug 2016 1:00 pm RNS Director Declaration
16th Aug 2016 7:00 am RNS AstraZeneca completes agreement with LEO Pharma
10th Aug 2016 2:41 pm RNS ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA
9th Aug 2016 7:00 am RNS ASTRAZENECA UPDATE ON SELUMETINIB PHASE III TRIAL
1st Aug 2016 2:30 pm RNS Total Voting Rights
1st Aug 2016 11:00 am RNS Director/PDMR Shareholding
28th Jul 2016 7:00 am RNS AZN: H1 2016 Results
27th Jul 2016 9:00 am RNS Notice of Results
19th Jul 2016 2:15 pm RNS QTERN (saxa/dapa) EU approved for type-2 diabetes
18th Jul 2016 7:00 am RNS TAGRISSO MET PRIMARY ENDPOINT IN PHASE III TRIAL
14th Jul 2016 12:07 pm RNS Second Price Monitoring Extn
14th Jul 2016 12:02 pm RNS Price Monitoring Extension
13th Jul 2016 7:00 am RNS AZ resolves Faslodex patent litigation in the US
1st Jul 2016 5:30 pm RNS Total Voting Rights
28th Jun 2016 7:00 am RNS Zavicefta approved in EU
23rd Jun 2016 7:00 am RNS AstraZeneca updates on Flumist vaccine in the US
14th Jun 2016 3:00 pm RNS Director/PDMR Shareholding
9th Jun 2016 7:03 am RNS AZ agreement with Aspen for anaesthetics portfolio
3rd Jun 2016 7:00 am RNS AZ completes US licensing agreement with Ironwood
2nd Jun 2016 7:00 am RNS AZ LICENSES ZURAMPIC TO GRÜNENTHAL GMBH
1st Jun 2016 12:00 pm RNS Block listing Interim Review
1st Jun 2016 11:30 am RNS Total Voting Rights
27th May 2016 12:36 pm RNS POSITIVE CHMP OPINION IN EU FOR SAXA/DAPA
27th May 2016 7:03 am RNS Positive results from AstraZeneca Faslodex trial
27th May 2016 7:00 am RNS AstraZeneca receives CRL from US FDA for ZS-9
23rd May 2016 4:00 pm RNS Director/PDMR Shareholding
18th May 2016 7:00 am RNS TOP-LINE RESULTS FROM LYNPARZA GOLD TRIAL
17th May 2016 7:00 am RNS POSITIVE BENRALIZUMAB RESULTS IN SEVERE ASTHMA
12th May 2016 7:00 am RNS SELUMETINIB GRANTED ORPHAN DRUG DESIGNATION IN US
11th May 2016 5:30 pm RNS Publication of Final Terms
9th May 2016 5:35 pm RNS Launch and pricing of EUR2.2bn bond issues
5th May 2016 3:00 pm RNS Publication of a Prospectus
3rd May 2016 1:30 pm RNS Total Voting Rights
3rd May 2016 7:01 am RNS AstraZeneca completes divestment of Imdur
3rd May 2016 7:00 am RNS AZ COMPLETES ACQUISITION OF TAKEDA RESPIRATORY
29th Apr 2016 5:30 pm RNS Result of AGM
29th Apr 2016 12:46 pm RNS POSITIVE CHMP OPINION FOR CAZ AVI
29th Apr 2016 7:00 am RNS AZN: 1st Quarter Results
FTSE 100 Latest
Value8,275.66
Change0.00